Stephen has a 30-year career in founding, investing in and building information technology companies. He is recognized for his leadership in data mining, analytics and business intelligence related ventures. Stephen was Founder, lead investor and served as Chairman of the Board and Chief Executive Officer of Explorys. Formed in partnership with Cleveland Clinic, Explorys addresses the national imperative to leverage electronic medical records for the improvement of Healthcare. Explorys was acquired by IBM [NYSE: IBM] in April 2015. Prior to Explorys he served as the Chairman of the Board and CEO of Everstream, the company he
founded in 1999 which was sold to Concurrent [NASDAQ: CCUR] in 2005. In 1985, Stephen founded McHale and Associates, Inc., a USConnect regional office, where he served as Chairman of the Board and CEO. He was a founding investor and served on the Board of Directors and as CEO of the parent USConnect, an international systems integrator until its sale to IKON Office Systems [NYSE: IKN] in 1997. Stephen is Managing Director of 23Bell LLC Investments and an active Advisory Board Member to Genesis Inventions.
Stephen serves on the Board of Directors for the Center for Families and Children, a non-profit organization that makes success possible for families in Northeast Ohio’s most challenged communities. Stephen serves on the investment screening committee for the North Coast Angel Fund and is a member of The Global Center for Health Innovation Industry Advisory Board. He is also an active member of the Entrepreneurs Organization and Kent State University’s Health Informatics Advisory Council.
Toby Cosgrove, MD, is former CEO and president of Cleveland
Clinic. Serving from 2004 through 2017, he led the $8 billion
organization to new heights of achievement and efficiency, seeing
it ranked the #2 hospital in America (U.S. News). He currently
serves as Executive Advisor, working with Cleveland Clinic
leadership on strategies for national and international growth.
Dr. Cosgrove graduated from Williams College and the University
of Virginia School of Medicine. He trained at Massachusetts
General Hospital and Brook General Hospital in London. In 1967,
he was a surgeon in the U.S. Air Force, earning a Bronze Star.
Dr. Cosgrove joined Cleveland Clinic in 1975, and chaired the
Department of Thoracic and Cardiovascular surgery from 1989 to
2004. He performed over 22,000 operations and earned an
international reputation in valve repair He holds 30 patents for
medical innovations. As CEO from 2004 to 2017, he reorganized
services, improved outcomes and patient experience, and
strengthened the organization’s finances.
He is a member of the National Academy of Medicine, and a
Fellow of the National Academy of Inventors. In 2016, he was a
Fortune Businessperson of the Year (No. 14). Three successive
presidents of the United States have consulted him on healthcare
Steven Lindseth has founded/co-founded and invested in companies in healthcare devices, technology enabled services, digital media and enterprise software. He has served on numerous boards and participated in raising dozens of rounds of equity and debt financing from both venture capital and corporate sources.
He is a senior advisor to Triple Tree, a leading healthcare technology merchant bank and private equity firm. He is on the boards of Imagescan (transactional content management), Nucleus Health, (a leader in tele- radiology and related image sharing technology) and Cleveland Clinic Innovations, which oversees innovation commercialization for that institution. He is an advisor to Healthprize, (a prescription medication adherence company), Knowledge Factor, (a leader in neuroscience-based education), Cyft (a new tool to enable anyone to build predictive models), and Fitzroy Health, (building and advising tech-enabled healthcare companies). He is a consultant to Partners Healthcare (Mass. General and Brigham & Women's Hospitals), Mercy Health, Ariadne Labs and Anschutz Medical Campus/University of Colorado.
Steve has been a founding investor in numerous prior ventures including: Dental Research Corp (the maker of the Interplak Toothbrush) which sold to Bausch & Lomb; Thermoscan (the maker of the Thermoscan Thermometer) which sold to Gilette; Complient (an outsource provider of emergency medical response services) which sold to Cardiac Science; Axentis (a provider of compliance software for the pharmaceutical industry) which sold to Wolters Kluwer; Explorys (a clinical big data management company) which sold to IBM; and YouBeauty (a women’s digital media wellness business) which sold to Caivis Holdings.
Jeffrey Patton, M.D. serves as Chief Executive Officer and Chairman of the
Board for Nashville-based Tennessee Oncology, one of the largest
community oncology practices in the U.S.
He is nationally recognized in the oncology community for his extensive
clinical trial research and scholarly publications on advancing cancer
treatment and bringing exceptional care to the communities where
patients live. Dr. Patton has published eight manuscripts and nearly 20
clinical trial abstracts on cancer treatment research. He specializes in all
adult malignancies and holds memberships in the Tennessee Oncology
Practice Society and the American Society of Clinical Oncology, where he
serves on the ASCO Clinical Practice Committee.
Dr. Patton, a graduate of Eastern Virginia Medical School in Norfolk,
completed his residency and fellowship at Wake Forest University in
Winston-Salem, N.C., where he served as Chief Resident. He also holds a
B.A. in Psychology from the University of Virginia. He currently serves as
Chairman of the Southern Oncology Board of Directors and is on the board
of directors for PearlPoint Cancer Support. He previously served as Chief of
Staff for Southern Hills Medical Center and on the board of directors for the
Sarah Cannon Research Institute.
Dr. Patton is also co-founder and Chief Medical Officer of Raintree
Oncology Services, a provider of comprehensive oral drug acquisition and
management services to help community oncology practices improve and
advance patient care.
Albert has worked with multiple Peloton Equity portfolio companies, including in deal diligence for HealthPlanOne, Inc. and Identity Theft Guard Solutions, Inc. Most significantly, Albert has served as the Chief Information and Chief Technology Officer for AeroCare Holdings, Inc. (Peloton I/FFC II), since 2014. At AeroCare, Albert is focused on technology operations, product development, and technology strategy. Prior to joining AeroCare, he served as an SVP at UnitedHealth Group, as CTO of the Optum Cloud. Prior to working with UnitedHealth, he served as CIO/CTO of Connextions Inc., a company that specialized in consumer driven healthcare solutions for payors, and was sold to Optum (a UnitedHealth Group company) in August of 2011 for approximately $350 million. Before Connextions, Albert was CIO of Rotech Medical Corporation, a publicly traded medical equipment company.
Albert is an active investor in healthcare and technology companies and and currently serves on the Board of Directors of NucleusHealth, MetisMachine, RxRevu™, HCF Enterprises and HCF Reality. Albert holds a B.A. from the University of Michigan and a M.B.A. from Rollins College
Our mission: improving the value of healthcare through better prescription decisions.learn more
To create lasting change in healthcare requires a dedicated intention and aligned effort. We are committed to investing in the future of healthcare.
Information is power and access to information empowers decision making. Transparency is required to unlock the power of information.
Accountability is taking ownership for our actions and their consequences. We support our partners and our teammates responsibly as we solve complex healthcare problems together.
We put ourselves in our partners' shoes, giving them the information they need to make complex prescribing decisions and supporting their needs.
It takes courage to innovate in healthcare. We have to take risks to succeed and sometimes that means failing. We take risks, innovate bravely and venture into unchartered territories.
At RxRevu, we support a diverse culture that values critical thinking, speaking with integrity, and contributing constructively to common goals. We assume the best intentions and value every individual.